Systemic therapy for early-stage HER2-positive breast cancers: Time for a less-is-more approach?

Author: Paplomata Elisavet   Nahta Rita   O'Regan Ruth M.  

Publisher: Blackwell Publishing

E-ISSN: 1097-0142|121|4|517-526

ISSN: 0008-543X

Source: Cancer, Vol.121, Iss.4, 2015-02, pp. : 517-526

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content